These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20346017)

  • 1. Successful treatment of disseminated intravascular coagulation in a child with acute myelogenous leukaemia using recombinant thrombomodulin.
    Ogawa E; Yagasaki H; Kato M; Shichino H; Chin M; Mugishima H
    Br J Haematol; 2010 Jun; 149(6):911-2. PubMed ID: 20346017
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.
    Maruyama I
    Thromb Haemost; 1999 Aug; 82(2):718-21. PubMed ID: 10605773
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.
    Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human soluble thrombomodulin for the treatment of hepatic sinusoidal obstructive syndrome post allogeneic hematopoietic SCT.
    Nakamura D; Yoshimitsu M; Kawada H; Inoue H; Kuroki T; Kaieda T; Fujino S; Hamada H; Suzuki S; Matsushita K; Uozumi K; Arima N
    Bone Marrow Transplant; 2012 Mar; 47(3):463-4. PubMed ID: 21552299
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
    Kawasugi K
    Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombomodulin-relationship thrombotic marker and therapeutic effect].
    Nomura S
    Rinsho Byori; 2011 Feb; Suppl 147():188-93. PubMed ID: 21761770
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan".
    Wada H; ; Okamoto K; Iba T; Kushimoto S; Kawasugi K; Gando S; Madoiwa S; Uchiyama T; Mayumi T; Seki Y
    Thromb Res; 2014 Oct; 134(4):924-5. PubMed ID: 25135793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of recombinant thrombomodulin in septic patients].
    Eguchi Y
    Rinsho Byori; 2011 Feb; Suppl 147():177-80. PubMed ID: 21761768
    [No Abstract]   [Full Text] [Related]  

  • 12. [How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers].
    Eguchi Y; Yoshida T; Okabe H
    Rinsho Byori; 2011 Feb; Suppl 147():213-5. PubMed ID: 21761775
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of DIC associated with myelogenous leukemia].
    Sakata Y
    Nihon Rinsho; 2009 Oct; 67(10):1978-83. PubMed ID: 19860201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
    Masuda S; Adachi O; Ito K; Matsuo S; Hayatsu Y; Suzuki Y; Saito T; Akiyama M; Kumagai K; Motoyoshi N; Kawamoto S; Saiki Y
    Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
    Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
    Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in the treatment with recombinant thrombomodulin on disseminated intravascular coagulation with severe urinary tract infection].
    Fumino M; Kurimoto K; Kinoshita N; Kato H; Arima K; Sugimura Y
    Hinyokika Kiyo; 2012 Feb; 58(2):71-4. PubMed ID: 22450831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effective.
    Fink MP
    Crit Care Med; 2013 Sep; 41(9):2221-3. PubMed ID: 23979366
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
    Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
    Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545
    [No Abstract]   [Full Text] [Related]  

  • 20. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
    Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
    Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.